Clinical Trials in North America

US Studies

NSABP C-11: A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases (NCT01189227)

International, Phase II Study of CyberKnife® for Hepatic Metastases From Colorectal Cancer (NCT01318447)

A Phase I/II Trial of Radioimmunotherapy (Y-90 cT84.66), Gemcitabine and Hepatic Arterial Infusion of Fudr for Metastatic Colorectal Carcinoma to the Liver (NCT00645710)

A Phase II Trial of Radioimmunotherapy (Y-90 M5A) Following Hepatic Resection and FOLFOX Chemotherapy for Metastatic Colorectal Carcinoma to the Liver (NCT01320683)

Phase II study of Neoadjuvant XELOX/AVASTIN Therapy for Nonresectable Colorectal Liver Metastases With Secondary Hepatic Resection/Radiofrequency (NCT00408772)

Phase II Study of Drug-eluting Irinotecan Beads (DEBIRI) in Refractory Metastatic Colorectal Cancer With Liver-only or Liver-predominant Disease (NCT01285102)

Safety Profile Assessment of TheraSphere® Yttrium-90 Glass Microspheres Used for Treatment of Metastatic Liver Disease From Primary Colorectal, Neuroendocrine, Cholangiocarcinoma, Melanoma, and Breast Cancers Refractory to Chemotherapy: A Phase II Pilot Study (NCT01290536)

Canadian Study

A Phase II Study of Fractionated Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors (NCT00691691)

Copyright © 2008-2009 Research To Practice. All Rights Reserved.